Sector valuations Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.67 USD | +1.97% |
|
+3.04% | +19.07% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -11.28x | - | -0.04x | - | - | - | - | 1.58B | ||
| 30.2x | 3.87x | 1.33x | 5.35x | 16.57x | 23.25x | 1.09% | 43.24B | ||
| -20.85x | 15.22x | -0.62x | 310.12x | -19.1x | -18.78x | -.--% | 35.25B | ||
| 40.55x | 6.05x | 0.25x | 4.04x | 25.86x | 30.6x | -.--% | 30.22B | ||
| 20.42x | 3.87x | 4.23x | 2.41x | 10.42x | 15.88x | -.--% | 28.01B | ||
| 28.37x | 2.09x | 0.84x | 7.35x | 18.9x | 22.56x | 0.44% | 24.08B | ||
| 26.74x | 13.39x | 2.32x | 4.27x | 19.45x | 20.4x | -.--% | 13.01B | ||
| 22.04x | 2.31x | 0.76x | 1.91x | 8.4x | 13.3x | 1.21% | 12.7B | ||
| -21.01x | 313.43x | -0.41x | 13.85x | -20.61x | -20.03x | -.--% | 12.54B | ||
| 22.13x | 1.1x | 0.19x | 1.64x | 9.93x | 11.37x | -.--% | 10.78B | ||
| -23.77x | 21.2x | -0.56x | 5.8x | 142.18x | -447.42x | -.--% | 8.59B | ||
| 47.69x | 4.04x | 0.31x | 7.14x | 20.26x | 22.2x | 0.58% | 8.71B | ||
| 29.6x | 2.65x | -0.1x | 2.74x | 10.68x | 12.97x | -.--% | 8.75B | ||
| -20x | 7.55x | -1.6x | 1748.03x | -16.76x | -15.95x | -.--% | 8.46B | ||
| -22.85x | 38.77x | 1.03x | 1666.23x | -23.8x | -24.65x | -.--% | 7.83B | ||
| 17.3x | 1.97x | 2.14x | 3.72x | 9.92x | 12.71x | -.--% | 7.5B | ||
| -115.73x | 4.16x | 0.91x | 4.77x | 25.28x | 151.86x | -.--% | 7.67B | ||
| -28.23x | 7.27x | 6.21x | 80.98x | -18.17x | -17.53x | -.--% | 8.18B | ||
| 29.5x | - | -0.1x | 13.4x | 23.88x | 25.96x | -.--% | 7.4B | ||
| Average | 2.67x | 26.41x | 0.90x | 215.76x | 13.52x | -10.07x | 0.18% | 14.97B | |
| Weighted average by Cap. | 10.50x | 21.44x | 1.00x | 143.47x | 11.45x | 0.02x | 0.28% |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















